Huijuan Wang
- Topics
- Multiple Myeloma Research and Treatments (14 papers)Peptidase Inhibition and Analysis (13 papers)Ferroptosis and cancer prognosis (6 papers)
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaBlood
- Partner nations
- ChinaUnited StatesFiji
In The Last Decade
Huijuan Wang
99 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 140
- Molecular Biology 362
- Oncology 197
- Epidemiology 181
- Pulmonary and Respiratory Medicine 160
- Surgery 143
Countries citing papers authored by Huijuan Wang
This map shows the geographic impact of Huijuan Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huijuan Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huijuan Wang more than expected).
Fields of papers citing papers by Huijuan Wang
This network shows the impact of papers produced by Huijuan Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huijuan Wang. The network helps show where Huijuan Wang may publish in the future.
Co-authorship network of co-authors of Huijuan Wang
This figure shows the co-authorship network connecting the top 25 collaborators of Huijuan Wang. A scholar is included among the top collaborators of Huijuan Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huijuan Wang. Huijuan Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 1 | |
| 3 | 19 | |
| 4 | 1 | |
| 5 | 3 | |
| 6 | 5 | |
| 7 | 5 | |
| 8 | 3 | |
| 9 | 11 | |
| 10 | 0 | |
| 11 | 1 | |
| 12 | 1 | |
| 13 | 0 | |
| 14 | 15 | |
| 15 | 2 | |
| 16 | 48 | |
| 17 | 1 | |
| 18 | 17 | |
| 19 | 6 | |
| 20 | 4 |
About Huijuan Wang
Huijuan Wang is a scholar working on Oncology, Hematology and Critical Care and Intensive Care Medicine, having authored 112 papers that have together received 1.2k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (14 papers), Peptidase Inhibition and Analysis (13 papers) and Ferroptosis and cancer prognosis (6 papers). The work is most often cited by research in Hematology (101 citations), Oncology (197 citations) and Analytical Chemistry (64 citations). Huijuan Wang has collaborated with scholars based in China, United States and Fiji. Frequent co-authors include Ying Zhang, Guosheng Ding, Shiji Qin, Longxiang Su, Fengqi Zhang, Peng Yan, Haitao Zhao, Lihui Xu, Yaning Sun and Kun Xiao. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.